Jump to content
  • Sign Up
0
Scott Adams

ImmusanT starts trials on celiac disease vaccine - Boston Herald

Rate this topic

Recommended Posts

Celiac.com

ImmusanT starts trials on celiac disease vaccine

Boston Herald

Cambridge-based ImmusanT said today it has initiated clinical trials in New Zealand, Australia and the United States to evaluate its celiac disease vaccine Nexvax2. The vaccine is designed to re-establish patients' tolerance to the toxic effects of ...

Celiac Disease More Prevalent in North Indian, Asian Populations Celiac.com

ImmusanT Initiates Clinical Trials of Nexvax2 Therapeutic Vaccine for Celiac ... Sacramento Bee

Just like dominos this menu item shall fall QSRweb.com (blog)

Lincoln Journal Star

all 13 news articles »

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×